Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells

Gynecologic Oncology

Volumn 80, Issue 2, 2001, Pages 168-175

  Moon, Mi Sun ^a   Lee, Chan Jae ^d   Um, Soo Jong ^b   Park, Jong Sup ^c   Yang, Jae Myung ^a   Hwang, Eun Seong ^d  

^a Sogang University   (South Korea)

^b Sejong University   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d University of Seoul   (South Korea)

Author keywords

BPV1 E2; Cdc25A; Cervical cancer; E2F1; HPV; p53

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN DEPENDENT KINASE 2; HAPTOCORRIN; ONCOPROTEIN; PROTEIN BPV1 E2; PROTEIN E6; PROTEIN E7; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; VIRUS ONCOGENE; WART VIRUS; WESTERN BLOTTING;

EID: 0035134457     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6053     Document Type: Article

References (51)

1. Association between poor prognosis in early-state invasive cervical carcinomas and non-detection of HPV DNA
2. In situ hybridization detection of human papillomaviurs DNA and messenger RNA in genital condylomas and a cervical cercinoma
3. Human papillomaviruses and cervical cancer
4. Human papillomvirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
5. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
6. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
7. The retinoblastoma protein binds to a family of E2F transcription factors
8. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
9. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein
10. Telomerase activation by the E6 gene product of human papillomavirus type 16
11. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein
12. Both Rb/pl 6INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
13. Human papillomaviruses in the pathogenesis of anogenital cancer
14. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins
15. Transactivation of an upstream early gene promoter of bovine papillomavirus-1 by a product of the viral E2 gene
16. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity
17. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein
18. The functional BPV1-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex
19. Integration of human papillomavirus type 16 DNA sequences: Possible early event in the progression of genital tumors
20. Transcriptional differences of the human papillomavirus type 16 genome between precancerous lesions and invasive carcinomas
21. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene
22. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene
23. WAF1, a potential mediator of p53 tumor suppression
24. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
25. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
26. p21 is a universal inhibitor of cyclin kinases
27. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F
28. The E2F transcription factor is a cellular target for the Rb protein
29. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines
30. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15
31. Cdc25A is a novel phosphatase functioning early in the cell cycle
32. Cdc25 protein phosphatase in cell proliferation
33. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein
34. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia
35. Prevalence of HPV in premalignant and malignant cervical lesions in Greenland and Denmark: PCR and in situ hybridization analysis on archival material
36. Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions
37. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix
38. Human papillomavirus infection in Norwegian women with cervical cancer
39. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
40. Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology
41. Establishment and characterization of 12 uterine cervical-carcinoma cell lines: Common sequence variation in the E7 gene of HPV-16-positive cell lines
42. Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus
43. The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell line in vitro and in vivo
44. The MDM2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
45. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression
46. Cdc25 cell-cycle phosphatase as a target of c-myc
47. E2F and histone deacetylase mediate transforming growth factor β repression of cdc25A during keratinocyte cell cycle arrest
48. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis
49. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells
50. Induction of senescence-like state in HeLa cells by the expression of bovine papillomavirus E2 gene
51. Rapid induction of senescence in human cervical carcinoma cells